Publication: Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
| dc.contributor.author | SİLİ, ULUHAN | |
| dc.contributor.authors | Salmanton-García J., Marchesi F., Glenthøj A., Bilgin Y. M., Van Praet J., Dávila-Valls J., Martín-Pérez S., Labrador J., Van Doesum J., Falces-Romero I., et al. | |
| dc.date.accessioned | 2022-12-28T15:54:23Z | |
| dc.date.accessioned | 2026-01-11T06:19:13Z | |
| dc.date.available | 2022-12-28T15:54:23Z | |
| dc.date.issued | 2022-11-25 | |
| dc.identifier.citation | Salmanton-García J., Marchesi F., Glenthøj A., Bilgin Y. M., Van Praet J., Dávila-Valls J., Martín-Pérez S., Labrador J., Van Doesum J., Falces-Romero I., et al., "Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report", HemaSphere, cilt.6, sa.11, 2022 | |
| dc.identifier.doi | 10.1097/hs9.0000000000000789 | |
| dc.identifier.issn | 2572-9241 | |
| dc.identifier.issue | 11 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85143836045&origin=inward | |
| dc.identifier.uri | https://hdl.handle.net/11424/284566 | |
| dc.identifier.volume | 6 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | HemaSphere | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Tıp | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Hematoloji | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Medicine | |
| dc.subject | Internal Medicine Sciences | |
| dc.subject | Internal Diseases | |
| dc.subject | Hematology | |
| dc.subject | Health Sciences | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | HEMATOLOJİ | |
| dc.subject | Clinical Medicine (MED) | |
| dc.subject | CLINICAL MEDICINE | |
| dc.subject | HEMATOLOGY | |
| dc.title | Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report | |
| dc.type | article | |
| dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
